Form SC 14D1 - Tender offer statement.:
SEC Accession No. 0000912057-96-005991
Filing Date
1996-04-04
Accepted
1996-04-04 00:00:00
Documents
12
SROs
CSENYSEPSE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14D-1 SC 14D1 14675
2 OFFER TO PURCHASE J2255 EX-99.(A)(1) 152202
3 LETTER OF TRANSMITTAL J2256 EX-99.(A)(2) 37978
4 FORM LETTER TO STOCKHOLDERS J2258 EX-99.(A)(3) 6783
5 BROKER DEALER LTR J2259 EX-99.(A)(4) 7191
6 NOTICE OF GURARANTEED DELIVERY J2257 EX-99.(A)(5) 7336
7 TAX GUIDELINES EX-99.(A)(6) 9265
8 TOMBSTONE AD J2261 EX-99.(A)(7) 13823
9 FORM OF PRESS RELEASE EX-99.(A)(8) 3822
10 FORM OF STOCKHOLDER LETTER J2261 EX-99.(A)(9) 2620
11 AGMT AND PLAN OF MERGER J2261 EX-99.(C)(1) 132705
12 CONFIDENTIALITY AGMT J2261 EX-99.(C)(2) 16163
  Complete submission text file 0000912057-96-005991.txt   407661
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 (708)-937-61
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 266 SECOND AVE WALTHAM MA 02154
Business Address 266 SECOND AVE WALTHAM MA 02154 6178956000
MEDISENSE INC /MA/ (Subject) CIK: 0000922872 (see all company filings)

EIN.: 042728017 | State of Incorp.: MA | Fiscal Year End: 0331
Type: SC 14D1 | Act: 34 | File No.: 005-43527 | Film No.: 96544425
SIC: 2835 In Vitro & In Vivo Diagnostic Substances